| ²é¿´: 185 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßgeminie½«ÔùËÍÄú 1 ¸ö½ð±Ò | |||
geminieľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
thymidine incorporation technique Ôõô·Òë
|
||
|
ÇëÎʸ÷λ¸ßÊÖthymidine incorporation technique Ôõô·Ò룬¾ßÌåÕâ¸ö¼¼Êõ¿ÉÒԲο¼ÄÄЩÖÐÎÄ×ÊÁÏ£¿ лл |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸211£¬0703»¯Ñ§305·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
22408 µ÷¼Á²ÄÁÏ
ÒѾÓÐ5È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
Ò»Ö¾Ô¸»ª¶«Àí¹¤085601²ÄÁϹ¤³Ì303·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0703»¯Ñ§
ÒѾÓÐ22È˻ظ´
»ªÄÏÀí¹¤0703»¯Ñ§£¬×Ü·Ö336Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ
ÒѾÓÐ10È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ
ÒѾÓÐ10È˻ظ´
µ÷¼Á
ÒѾÓÐ11È˻ظ´
zfcsss
Òø³æ (СÓÐÃûÆø)
- ·ÒëEPI: 11
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 437.7
- É¢½ð: 12
- ºì»¨: 1
- Ìû×Ó: 145
- ÔÚÏß: 53.9Сʱ
- ³æºÅ: 599141
- ×¢²á: 2008-09-11
- רҵ: Óлú¸ß·Ö×Ó¹¦ÄܲÄÁÏ
¡ï ¡ï
geminie(½ð±Ò+2,VIP+0):thanks 8-6 15:03
geminie(½ð±Ò+2,VIP+0):thanks 8-6 15:03
|
thymidineÉãÈë¼¼Êõ,Ö»ÕÒµ½Õâ¸ö£¬²»ÖªµÀÓÐûÓÐÓà -------------------------------------------------------------------------------- ÀûÓøßͨÁ¿Ò©ÎïɸѡϵͳÑо¿ÆÏ¾ÛÌÇÑÜÉúÎïµÄ¿¹ÈéÏÙ°©»îÐÔ Ê¯ÎÀÎä¡¡ ½¯Ã÷¡¡ »Æ½ð÷ë¡¡ ²Ü½¨»ª¡¡ »ÆË¼ÂÞ¡¡ Áõ½£·å¡¡ Õª¡¡Òª£ºÄ¿µÄ Ñо¿ÆÏ¾ÛÌÇÑÜÉúÎï¶ÔÈéÏÙ°©µÄ×÷ÓÃ.·½·¨ ÒÔ¸ÎËØ±í´ïȱÏݶøÎȶ¨±í´ï³ÉÏËάϸ°ûÉú³¤Òò×ÓÊÜÌå(FGFR)µÄF32ϸ°ûϵºÍÈéÏÙ°©Ï¸°ûϵMCF-7¡¢MCF-7rasΪģÐÍ,ÀûÓÃ3 H-thymidineÉãÈë¼¼Êõ,Ñо¿È˹¤ºÏ³ÉµÄÆÏ¾ÛÌÇÑÜÉúÎï¶Ôϸ°ûÉú³¤µÄÓ°Ïì,²¢³õ²½Ì½ÌÖÆä×÷ÓûúÖÆ.½á¹û ÆÏ¾ÛÌÇÑÜÉúÎïÄܹ»ÓÐЧ×÷ÓÃÓÚHS/FGF/FGFR¸´ºÏÎï,µ«¶ÔÁ½ÖÖÈéÏÙ°©Ï¸°ûϵ¾ßÓÐÍêÈ«Ïà·´µÄÁ½ÖÖ×÷ÓÃ,¼´´Ì¼¤MCF-7µÄÉú³¤¶ø¶ÔMCF-7rasÔòÒÖÖÆÉú³¤.¹¹Ð§Ñо¿·¢ÏÖ,»ÇËá»ùÍźͱ½»·ÊÇÓ°ÏìÆÏ¾ÛÌÇÑÜÉúÎï»îÐÔÖØÒª»ùÍÅ.½áÂÛ ÆÏ¾ÛÌÇÑÜÉúÎïÓë¸ÎËØ¾ßÓÐÏàËÆµÄÐÔÖÊ,¶Ôϸ°ûÉú³¤¾ßÓÐË«ÖØÐÔ. |
2Â¥2008-10-06 12:09:04
sxyzt
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 6256.5
- É¢½ð: 1338
- ºì»¨: 12
- Ìû×Ó: 4053
- ÔÚÏß: 963.9Сʱ
- ³æºÅ: 523516
- ×¢²á: 2008-03-12
- רҵ: ¹¤³ÌÈÈÎïÀíÏà¹Ø½»²æÁìÓò
¡ï ¡ï
geminie(½ð±Ò+2,VIP+0):thank you 8-6 15:03
geminie(½ð±Ò+2,VIP+0):thank you 8-6 15:03
|
Platelet derived growth factor (PDGF), content in hypoxic endothelial cells conditioned medium (HECCM) and normoxic endothelial cells conditioned medium (NECM) was determined using protein dot blot assay. The effects of HECCM and NECCM on the growth of pulmonary artery smooth muscle cells (PASMC) were assessed with thymidine incorporation technique and flow cytometric analysis. Ó¦Óõ°°×dotblot¼¼Êõ¼ì²âÁ˵ÍÑõÄÚÆ¤Ï¸°ûÌõ¼þÅàÑøÒº£¨HECCM£©ºÍ³£ÑõÄÚÆ¤Ï¸°ûÌõ¼þÅàÑøÒº£¨NECCM£©ÄÚPDGFÏà¶Ôº¬Á¿£¬²¢ÀûÓãÛ3H£Ý£TdR²ôÈë·¨ºÍÁ÷ʽϸ°ûÊõ¹Û²ìÁËHECCMºÍNECCM¼°¼ÓÈëÌØÒìPDGF¿¹Ìå¶Ô·Î¶¯Âöƽ»¬¼¡Ï¸°û£¨PASMC£©Éú³¤µÄÓ°Ïì¡£ |
3Â¥2008-10-06 12:27:25














»Ø¸´´ËÂ¥